Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. It primarily focuses on developing innovative therapies for inflammation and pain management in knee osteoarthritis (OA) and, to a lesser extent, multiple sclerosis (MS). The company was founded on May 11, 2020 and is headquartered in Hopewell, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
2
Frequently Asked Questions
What is Market Cap of Apimeds Pharmaceuticals US Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Apimeds Pharmaceuticals US Inc. market cap is $23.97M.
What is the 52-week high for Apimeds Pharmaceuticals US Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Apimeds Pharmaceuticals US Inc. 52 week high is $4.00 as of September 09, 2025.
What is the 52-week low for Apimeds Pharmaceuticals US Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Apimeds Pharmaceuticals US Inc. 52 week low is $1.37 as of September 09, 2025.
What is Apimeds Pharmaceuticals US Inc. stock price today?
Apimeds Pharmaceuticals US Inc. stock price today is $1.83.
What was Apimeds Pharmaceuticals US Inc. stock price yesterday?
Apimeds Pharmaceuticals US Inc. stock price yesterday was $1.91.
What is the PE ratio of Apimeds Pharmaceuticals US Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Apimeds Pharmaceuticals US Inc.’s P/E ratio is -6.04.
What is the Price-to-Book ratio of Apimeds Pharmaceuticals US Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Apimeds Pharmaceuticals US Inc. P/B ratio is 2.4615.
What is the 50-day moving average of Apimeds Pharmaceuticals US Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Apimeds Pharmaceuticals US Inc. 50-day moving average is $1.82.
How many employess does Apimeds Pharmaceuticals US Inc. has?
